PACB

2.34

20.62% 0.40

Handel nachbörslich: 2.35 0.01 +0.43%

Pacific Biosciences Of California Inc (PACB)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt PACB? Forum Prognose

Schlusskurs vom Vortag:

$1.94

Offen:

$2.065

24-Stunden-Volumen:

22.62M

Relative Volume:

2.92

Marktkapitalisierung:

$702.87M

Einnahmen:

$188.87M

Nettoeinkommen (Verlust:

$-400.38M

KGV:

-1.56

EPS:

-1.5

Netto-Cashflow:

$-260.90M

1W Leistung:

+15.84%

1M Leistung:

+82.81%

6M Leistung:

+110.81%

1J Leistung:

+7.83%

1-Tages-Spanne:

$2.05

$2.37

1-Wochen-Bereich:

$1.91

$2.37

52-Wochen-Spanne:

$0.8511

$2.72

Pacific Biosciences Of California Inc Stock (PACB) Company Profile

Firmenname

Pacific Biosciences Of California Inc

Sektor

Healthcare (1135)

Branche

Medical Devices (144)

Telefon

650-521-8000

Adresse

1305 O'BRIEN DRIVE, MENLO PARK, CA

Mitarbeiter

575

Twitter

@pacbio

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

PACB's Discussions on Twitter

Vergleichen Sie PACB mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PACB Pacific Biosciences Of California Inc	2.34	582.72M	188.87M	-400.38M	-260.90M	-1.50
ABT Abbott Laboratories	123.62	216.79B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	100.72	149.02B	19.35B	2.78B	3.49B	1.8696
SYK Stryker Corp	356.24	141.06B	24.38B	2.94B	4.02B	7.6145
MDT Medtronic Plc	90.70	116.68B	34.20B	4.69B	5.30B	3.6218
EW Edwards Lifesciences Corp	82.45	49.01B	5.88B	1.34B	577.90M	2.3455

Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-11	Herabstufung	UBS	Buy → Neutral
2024-06-03	Fortgesetzt	Jefferies	Buy
2024-04-22	Herabstufung	JP Morgan	Overweight → Neutral
2024-04-18	Herabstufung	Goldman	Buy → Neutral
2023-12-14	Eingeleitet	Guggenheim	Neutral
2023-12-14	Eingeleitet	Stephens	Overweight
2023-12-13	Eingeleitet	Wolfe Research	Peer Perform
2023-11-17	Hochstufung	UBS	Neutral → Buy
2023-10-31	Hochstufung	Cantor Fitzgerald	Neutral → Overweight
2023-09-28	Eingeleitet	Bernstein	Outperform
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-06-30	Eingeleitet	Goldman	Buy
2023-05-10	Eingeleitet	Barclays	Equal Weight
2023-03-31	Hochstufung	TD Cowen	Market Perform → Outperform
2023-02-02	Eingeleitet	UBS	Neutral
2023-01-20	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2023-01-05	Eingeleitet	Scotiabank	Sector Outperform
2022-01-21	Fortgesetzt	Cantor Fitzgerald	Overweight
2022-01-06	Fortgesetzt	Piper Sandler	Neutral
2021-10-15	Fortgesetzt	Cowen	Market Perform
2021-09-27	Eingeleitet	Canaccord Genuity	Buy
2021-02-11	Hochstufung	Piper Sandler	Neutral → Overweight
2020-11-03	Herabstufung	Piper Sandler	Overweight → Neutral
2020-10-02	Hochstufung	JP Morgan	Neutral → Overweight
2020-09-09	Eingeleitet	Morgan Stanley	Equal-Weight
2020-06-02	Fortgesetzt	Cantor Fitzgerald	Overweight
2020-03-09	Fortgesetzt	Cantor Fitzgerald	Overweight
2019-10-15	Hochstufung	Piper Jaffray	Neutral → Overweight
2019-04-02	Herabstufung	Stephens	Overweight → Equal-Weight
2018-10-19	Eingeleitet	Cowen	Outperform
2017-11-03	Herabstufung	First Analysis Sec	Overweight → Equal-Weight
2017-09-28	Herabstufung	CL King	Buy → Neutral
2016-11-03	Bestätigt	Cantor Fitzgerald	Buy
2016-06-27	Eingeleitet	CL King	Buy
2016-04-15	Eingeleitet	First Analysis Sec	Overweight
2016-02-04	Herabstufung	Piper Jaffray	Overweight → Neutral
2016-01-04	Bestätigt	Cantor Fitzgerald	Buy
2015-10-23	Hochstufung	Piper Jaffray	Neutral → Overweight
2015-08-27	Eingeleitet	Cantor Fitzgerald	Buy
2015-02-04	Bestätigt	Maxim Group	Buy
2013-09-26	Bestätigt	Maxim Group	Buy
2013-01-14	Bestätigt	Maxim Group	Buy

Alle ansehen

Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten

02:49 AM

Does Pacific Biosciences of California Inc. stock trade at a discount to peersWall Street Watch & Capital Efficient Trade Techniques - newser.com

02:49 AM

02:44 AM

Will Pacific Biosciences of California Inc. stock split attract more investorsTrade Risk Assessment & Weekly High Momentum Picks - newser.com

02:44 AM

08:52 AM

What makes Pacific Biosciences of California Inc. stock attractive to growth fundsEarnings Overview Summary & Expert Approved Momentum Ideas - newser.com

08:52 AM

07:19 AM

Is Pacific Biosciences of California Inc. (P09) stock resilient in recession scenariosOptions Play & Weekly Chart Analysis and Guides - newser.com

07:19 AM

05:32 AM

Analyzing recovery setups for Pacific Biosciences of California Inc. investorsMarket Sentiment Review & Growth Focused Stock Pick Reports - newser.com

05:32 AM

03:04 AM

Will Pacific Biosciences of California Inc. continue its uptrendJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com

03:04 AM

02:50 AM

Will Pacific Biosciences of California Inc. stock sustain high P E ratios2025 Growth vs Value & Scalable Portfolio Growth Methods - newser.com

02:50 AM

01:52 AM

Is Pacific Biosciences of California Inc. stock ready for a breakoutEarnings Risk Report & Long-Term Investment Growth Plans - newser.com

01:52 AM

01:53 AM

Why Pacific Biosciences of California Inc. stock is favored by top institutionsJuly 2025 Selloffs & Safe Entry Point Identification - newser.com

01:53 AM

Nov 01, 2025

Can Pacific Biosciences of California Inc. stock resist market sell offsTrade Ideas & Verified Technical Signals - newser.com

Nov 01, 2025

What analysts say about Pacific Biosciences of California Inc P09 stockAutomated Trading Signals & Small Capital Wealth Plans - earlytimes.in

Nov 01, 2025

How to build a custom watchlist for Pacific Biosciences of California Inc.Insider Buying & Safe Capital Allocation Plans - newser.com

Nov 01, 2025

Pacific Biosciences of California (NASDAQ:PACB) Shares Gap UpHere's What Happened - MarketBeat

Nov 01, 2025

Pacific Biosciences of California (NASDAQ:PACB) Shareholders Are up 16% This Past Week, but Still in the Red Over the Last Five Years - 富途牛牛

Nov 01, 2025

Carret Asset Management LLC Buys New Holdings in Pacific Biosciences of California, Inc. $PACB - MarketBeat

Nov 01, 2025